‘A Guy Who Could Get a Line Into a Rock’: What We Heard This Week

News

“I was looking at a guy who could get a line into a rock.” — Eduardo Marban, MD, executive director of the Smidt Heart Institute of Cedars-Sinai, talking about a member of the COVID Line Team there.

“It was the kind of thing you do when you’re writing your sixth-grade report from the Encyclopedia Britannica and you have to make it look like you didn’t copy it right out of there.” — Amy Barnhorst, MD, of University of California Davis, alleging that her work had been plagiarized by the managing editor of a medical journal.

“You’re giving a key that fits into a lock and other keys don’t fit that lock.” — Gregory Poland, MD, of Mayo Clinic Vaccine Research Group, about COVID-19 vaccines for people taking monoclonal antibodies that target the calcitonin gene-related peptide (CGRP) pathway for migraine prevention.

“I don’t think we should approve drugs based on projections. We need solid evidence to prescribe drugs.” — Matthew Ellis, MD, of Baylor College of Medicine in Houston, discussing his vote to delay approval of a pembrolizumab (Keytruda)-containing regimen for early-stage, high-risk triple-negative breast cancer.

“Our goal should be to get all patients prepared for video telehealth visits and narrow the digital divide as best we can with the intention of moving exclusively to video visits in the future.” — Lori Uscher-Pines, PhD, of the RAND Corporation, on the future of virtual care and telehealth.

“They’re on the front line like other workers.” — Joe Pecora, vice president of Home Healthcare Workers of America, on the struggle to get COVID-19 vaccines to home healthcare workers.

Products You May Like

Articles You May Like

This Single-Serving Protein Cookie Recipe on TikTok Looks Fudgy and Delicious
Inflammatory Bowel Disease: Enormous Burden for Patients
KHN’S ‘What the health?’:Staffing up at HHS
Breast Cancer Survivor Opens Her Own Business 17 Years After Beating the Disease
Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis

Leave a Reply

Your email address will not be published. Required fields are marked *